Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
26th week of 2017 patent applcation highlights part 8
Patent application number
Title
Published
20170182070
Controlled Release Doxycycline
2017-06-29
20170182071
TETRACYCLINE TOPICAL FORMULATIONS, PREPARATION AND USES THEREOF IN TREATING AN OCULAR CONDITION
2017-06-29
20170182072
COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
2017-06-29
20170182073
CAPSULES CONTAINING HIGH DOSES OF KRILL PHOSPHOLIPIDS
2017-06-29
20170182074
LIQUID PHOSPHOLIPID-CONTAINING COMPOSITIONS FOR THE PREPARATION OF PHARMACEUTICALS
2017-06-29
20170182075
ANTI-AGING COMPOSITIONS AND METHODS FOR USING SAME
2017-06-29
20170182076
METHODS OF TREATING MITOCHONDRIAL DYSFUNCTION
2017-06-29
20170182077
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
2017-06-29
20170182078
AMINOGLYCOSIDES AND USES THEREOF IN TREATING GENETIC DISORDERS
2017-06-29
20170182079
METHOD OF TREATING HETEROTOPIC OSSIFICATION
2017-06-29
20170182080
FUNCTIONAL SCAFFOLD FOR TISSUE REPAIR AND REGENERATION
2017-06-29
20170182081
MANNOSE-CONTAINING SOLUTION FOR LYOPHILIZATION, TRANSFECTION AND/OR INJECTION OF NUCLEIC ACIDS
2017-06-29
20170182082
ANTISENSE COMPOUNDS
2017-06-29
20170182083
USE OF 15 MALE FERTILITY RELATED PROTEINS OR COMBINATION THEREOF
2017-06-29
20170182084
METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN (A) EXPRESSION
2017-06-29
20170182085
THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDER
2017-06-29
20170182086
COMPOSITIONS AND METHODS TO AFFECT SKIN IRRITATION
2017-06-29
20170182087
MAIN CHAIN POLYAMINES
2017-06-29
20170182088
METHOD AND APPARATUS FOR ADMINISTERING NITRIC OXIDE WITH SUPPLEMENTAL DRUGS
2017-06-29
20170182089
ADMINISTRATION OF A THIOL-BASED CHEMOPROTECTANT COMPOUND
2017-06-29
20170182090
Sulfate Salt Solution Laxative Compositions and Methods of Use Thereof
2017-06-29
20170182091
PRODUCTION OF WATER-SOLUBLE HYDROLYZED CLINOPTILOLITE FRAGMENTS
2017-06-29
20170182092
MULTICOMPONENT ORAL CARE COMPOSITION
2017-06-29
20170182093
COMPOSITIONS AND RELATED METHODS FOR TREATING AND PREVENTING VIRAL AND RETROVIRAL INFECTIONS
2017-06-29
20170182094
DIALYSIS SOLUTIONS COMPRISING ORGANIC ESTERS OF PHOSPHORIC ACID
2017-06-29
20170182095
METHODS AND COMPOSITIONS TO MODULATE HAIR GROWTH
2017-06-29
20170182096
LYMPHOCYTE MEDIATED DELIVERY OF PROTEINS
2017-06-29
20170182097
NON-HUMAN MAMMAL MODEL OF HUMAN DEGENERATIVE DISORDER, USES THEREOF, AND METHOD OF TREATING HUMAN DEGENERATIVE DISORDER
2017-06-29
20170182098
NON-HUMAN MAMMAL MODEL OF HUMAN DEGENERATIVE DISORDER, USES THEREOF, AND METHOD OF TREATING HUMAN DEGENERATIVE DISORDER
2017-06-29
20170182099
Induced Pacemaker and Purkinje Cells from Adult Stem Cells
2017-06-29
20170182100
CONDITIONED MEDIUM OF LIVER PROGENITOR CELLS
2017-06-29
20170182101
COMPOSITIONS AND METHODS OF USE OF NOVEL STRAINS OF LACTOBACILLUS FERMENTUM
2017-06-29
20170182102
TUBE FEED PACKAGES AND METHODS FOR USING SAME
2017-06-29
20170182103
Synergistic Nutritional Supplement for Absolute Energy
2017-06-29
20170182104
COMPOSITION CONTAINING MASTERWORT EXTRACT
2017-06-29
20170182107
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC COMPLICATIONS AND ANGIOEDEMA, CONTAINING NATURAL MIXTURE EXTRACT AS ACTIVE INGREDIENT
2017-06-29
20170182108
FERMENTED FOOD EXTRACT COMPOSITION
2017-06-29
20170182109
APPETITE-SUPPRESSING AGENT
2017-06-29
20170182110
AGENT FOR PREVENTING OR AMELIORATING DIABETES
2017-06-29
20170182111
Composition of extracts from the genus Hippeastrum and the use of their components for the production of pharmaceuticals and dietary supplements
2017-06-29
20170182112
Sugar Extract
2017-06-29
20170182113
Crosslinked Peptide Hydrogels
2017-06-29
20170182114
AURANTIAMIDE DIPEPTIDE DERIVATIVES FOR TREATMENT OR PREVENTION OF ANGIOGENESIS-RELATED DISEASES
2017-06-29
20170182115
PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER
2017-06-29
20170182116
SMAC Mimetic
2017-06-29
20170182117
THERAPEUTIC COMPOSITIONS INCLUDING THERAPEUTICSMALL MOLECULES AND USES THEREOF
2017-06-29
20170182118
PREPARATIONS CONTAINING AMORPHOUS EMODEPSIDE
2017-06-29
20170182119
Compositions And Methods For Modulating NCOA4-Mediated Autophagic Targeting Of Ferritin
2017-06-29
20170182120
METHOD OF TREATING OR PREVENTING POLYCYSTIC KIDNEY DISEASE AND PKD ANIMAL MODEL WITH EXOGENOUS NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN
2017-06-29
20170182121
CHARGED LIPOPROTEIN COMPLEXES AND THEIR USES
2017-06-29
20170182122
METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS AND DISEASES
2017-06-29
20170182123
METHODS AND USES FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES
2017-06-29
20170182124
FGF21 Derivatives and Uses Thereof
2017-06-29
20170182125
COMPOSITIONS FOR PROMOTING THE HEALING OF WOUNDS
2017-06-29
20170182126
METHOD FOR PREVENTION OR TREATMENT OF INTRACTABLE INFLAMMATORY BOWEL DISEASE
2017-06-29
20170182127
METHOD AND COMPOSITION FOR TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION
2017-06-29
20170182128
METHOD OF TREATING HEART FAILURE
2017-06-29
20170182129
SYSTEMIC DELIVERY OF VIRUS VECTORS ENCODING UROCORTIN-2 AND RELATED GENES TO TREAT DIABETES-RELATED CARDIAC DYSFUNCTIONS AND CONGESTIVE HEART FAILURE
2017-06-29
20170182130
METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
2017-06-29
20170182131
INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5
2017-06-29
20170182132
USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN SUPPORTING RESISTANCE TO DISEASES AND CONDITIONS
2017-06-29
20170182133
COMPOSITIONS FOR PROVIDING AGENTS THAT DEGRADE IN WATER
2017-06-29
20170182134
Delivery of Therapeutic Compounds to the Brain and Other Tissues
2017-06-29
20170182135
DRY POWDER FIBRIN SEALANT
2017-06-29
20170182136
COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO EIMERIA OR LIMITING EIMERIA INFECTION
2017-06-29
20170182137
BREAST AND OVARIAN CANCER VACCINES
2017-06-29
20170182138
IN SITU ANTIGEN-GENERATING CANCER VACCINE
2017-06-29
20170182139
CANCER THERAPY
2017-06-29
20170182140
INDUCED ACTIVATION IN DENDRITIC CELLS
2017-06-29
20170182141
M Hyo Multivalent Vaccine and Uses Thereof
2017-06-29
20170182142
ANTI-MYCOPLASMA SPP. SUBUNIT VACCINE
2017-06-29
20170182143
ANTI-MYCOPLASMA SPP. SUBUNIT VACCINE
2017-06-29
20170182144
ANTI-MYCOPLASMA SPP. SUBUNIT VACCINE
2017-06-29
20170182145
METHODS AND COMPOSITIONS FOR SUPPRESSING VIRULENCE OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS
2017-06-29
20170182146
POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING GRAM POSITIVE POLYPEPTIDES AND METHODS OF USE
2017-06-29
20170182147
CD40 LIGAND FUSION PROTEIN VACCINE
2017-06-29
20170182148
IMMUNOPOTENTIATOR-LINKED OLIGOMERIC INFLUENZA IMMUNOGENIC COMPOSITIONS
2017-06-29
20170182149
Composite Antigenic Sequences and Vaccines
2017-06-29
20170182150
VACCINATION WITH mRNA-CODED ANTIGENS
2017-06-29
20170182151
RSV F Protein Mutants
2017-06-29
20170182152
NON-TOXIC ADJUVANT FORMULATION COMPRISING A MONOPHOSPHORYL LIPID A (MPLA)-CONTAINING LIPOSOME COMPOSITION AND A SAPONIN
2017-06-29
20170182153
YEAST-BASED COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF HEPATITIS DELTA VIRUS INFECTION
2017-06-29
20170182154
VACCINES WITH INTERLEUKIN-17 AS AN ADJUVANT
2017-06-29
20170182155
SYNTHETIC GLUCOPYRANOSYL LIPID ADJUVANTS
2017-06-29
20170182156
METHODS FOR ENHANCING THE EFFICACY OF A TUMOR-DIRECTED IMMUNE RESPONSE
2017-06-29
20170182157
IMMUNOSTIMULATOR AND METHOD FOR PRODUCING THE SAME
2017-06-29
20170182158
QSOX1 AS AN ANTI-NEOPLASTIC DRUG TARGET
2017-06-29
20170182159
ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-6
2017-06-29
20170182160
METHODS OF TREATING ATOPIC DERMATITIS WITH IL-31 MONOCLONAL ANTIBODIES
2017-06-29
20170182161
Antigen Binding Proteins that Bind PD-L1
2017-06-29
20170182162
LIQUID PHARMACEUTICAL COMPOSITION
2017-06-29
20170182163
MULTI-SPECIFIC ANTIBODIES FOR CROSS-NEUTRALIZATION OF MULTIPLE FILOVIRUS GLYCOPROTEINS
2017-06-29
20170182164
METHOD FOR TREATING CANCER
2017-06-29
20170182165
THERMAL ACCELERANT COMPOSITIONS AND METHODS OF USE
2017-06-29
20170182166
NOVEL COPPER-CYSTEAMINE AND METHODS OF USE
2017-06-29
20170182167
SILICONE-BASED COMPOSITION FOR SKIN TREATMENT
2017-06-29
20170182168
COMPOSITIONS OF A POLYORTHOESTER AND AN APROTIC SOLVENT
2017-06-29
20170182169
METHOD FOR BOWEL PREPARATION
2017-06-29
20170182170
Nitric Oxide Donors
2017-06-29
20170182171
MULTIPLE OLIGONUCLEOTIDE MOIETIES ON PEPTIDE CARRIER
2017-06-29